RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,569 | -100.0% | 4,703 | -99.5% | 0.00% | -100.0% |
| Q3 2022 | $33,584,000 | +39.0% | 907,190 | -28.7% | 0.13% | +31.4% |
| Q2 2022 | $24,166,000 | -31.8% | 1,272,574 | -3.0% | 0.10% | -27.7% |
| Q1 2022 | $35,422,000 | +66.1% | 1,312,400 | +38.7% | 0.14% | +65.9% |
| Q4 2021 | $21,320,000 | +269.8% | 946,313 | +330.1% | 0.08% | +240.0% |
| Q3 2021 | $5,766,000 | -7.4% | 220,000 | +13.1% | 0.02% | -10.7% |
| Q2 2021 | $6,226,000 | +2.5% | 194,510 | +12.8% | 0.03% | 0.0% |
| Q1 2021 | $6,074,000 | -33.5% | 172,500 | -39.5% | 0.03% | -37.8% |
| Q4 2020 | $9,140,000 | +21.9% | 285,000 | +43.0% | 0.04% | +18.4% |
| Q3 2020 | $7,497,000 | +1.8% | 199,291 | +21.1% | 0.04% | -20.8% |
| Q2 2020 | $7,364,000 | +37.9% | 164,559 | +20.2% | 0.05% | +71.4% |
| Q4 2019 | $5,339,000 | – | 136,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |